Min Chen Selected Research

Adenocarcinoma

9/2023	Partner of NOB1 homolog transcriptionally activated by E2F transcription factor 1 promotes the malignant progression and inhibits ferroptosis of pancreatic cancer.
1/2022	A Novel DNA Repair Gene Signature for Immune Checkpoint Inhibitor-Based Therapy in Gastric Cancer.
1/2018	Effects of proton pump inhibitors on reversing multidrug resistance via downregulating V-ATPases/PI3K/Akt/mTOR/HIF-1α signaling pathway through TSC1/2 complex and Rheb in human gastric adenocarcinoma cells in vitro and in vivo.
1/2017	Comparison of HER2 and Lauren Classification between Biopsy and Surgical Resection Samples, Primary and Metastatic Samples of Gastric Cancer.
1/2016	Elevated integrin α6β4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.
1/2016	Pantoprazole inhibits human gastric adenocarcinoma SGC-7901 cells by downregulating the expression of pyruvate kinase M2.
11/2015	Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).
7/2014	Immunohistochemical screening and fluorescence in situ hybridization confirmation of ALK translocation in lung adenocarcinoma and its clinicopathological significance: a single-center large-scale investigation of Chinese patients.
8/2013	Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho‑LRP6 expression in Wnt/β-catenin signaling.
7/2012	Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min Chen Research Topics

Disease

302	Neoplasms (Cancer) 05/2024 - 01/2002
104	Infections 04/2024 - 12/2003
94	Inflammation (Inflammations) 04/2024 - 03/2004
69	Breast Neoplasms (Breast Cancer) 01/2024 - 06/2005
68	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 04/2024 - 02/2007
55	Vasculitis (Vasculitides) 04/2024 - 11/2005
49	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2002
37	Carcinogenesis 02/2024 - 02/2010
35	Insulin Resistance 04/2024 - 07/2004
35	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 03/2005
34	Fibrosis (Cirrhosis) 04/2024 - 01/2007
33	Stomach Neoplasms (Stomach Cancer) 01/2023 - 09/2011
30	COVID-19 04/2024 - 07/2020
27	Hypoxia (Hypoxemia) 12/2023 - 09/2014
27	Glomerulonephritis 01/2021 - 02/2007
24	Carcinoma (Carcinomatosis) 12/2023 - 01/2009
23	Wounds and Injuries (Trauma) 04/2024 - 06/2003
23	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 02/2010
23	Body Weight (Weight, Body) 08/2023 - 06/2002
22	Stroke (Strokes) 02/2024 - 04/2006
22	Obesity 01/2024 - 07/2004
21	Hypertension (High Blood Pressure) 05/2024 - 01/2004
21	Chronic Hepatitis B 12/2023 - 04/2003
20	Type 2 Diabetes Mellitus (MODY) 10/2023 - 11/2009
19	Parkinson Disease (Parkinson's Disease) 04/2024 - 08/2007
19	Hemorrhage 01/2024 - 06/2009
19	Sepsis (Septicemia) 12/2023 - 04/2006
19	Ischemia 08/2023 - 08/2002
19	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 12/2002
17	Leukemia 01/2024 - 04/2013
17	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 10/2011
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 10/2010
16	Lung Neoplasms (Lung Cancer) 11/2023 - 09/2008
15	Chronic Obstructive Pulmonary Disease (COPD) 03/2024 - 04/2014
15	Atherosclerosis 01/2024 - 11/2002
15	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2004
15	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 12/2007
15	Asthma (Bronchial Asthma) 01/2022 - 10/2004
14	Alzheimer Disease (Alzheimer's Disease) 06/2024 - 11/2010
14	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2024 - 04/2005
14	Crohn Disease (Crohn's Disease) 04/2024 - 03/2007
14	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 12/2007
14	Proteinuria 01/2022 - 02/2007
14	Microscopic Polyangiitis 01/2019 - 01/2007
13	Colonic Neoplasms (Colon Cancer) 05/2024 - 05/2011
13	Diabetic Nephropathies (Diabetic Nephropathy) 02/2024 - 01/2017
13	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024 - 03/2007
13	Pneumonia (Pneumonitis) 11/2023 - 04/2012
13	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2023 - 03/2011
13	Ischemic Stroke 10/2023 - 01/2013
13	Adenocarcinoma 09/2023 - 09/2009

Drug/Important Bio-Agent (IBA)

133	Proteins (Proteins, Gene)FDA Link 01/2024 - 08/2002
90	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2024 - 11/2002
79	Biomarkers (Surrogate Marker)IBA 06/2024 - 05/2007
52	CytokinesIBA 01/2024 - 01/2005
47	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 08/2002
45	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 11/2005
39	AntibodiesIBA 12/2023 - 01/2005
37	MicroRNAs (MicroRNA)IBA 05/2024 - 03/2011
36	Messenger RNA (mRNA)IBA 03/2023 - 01/2002
33	AutoantibodiesIBA 12/2023 - 11/2002
32	VaccinesIBA 04/2024 - 04/2003
31	LipidsIBA 04/2024 - 10/2002
29	CreatinineIBA 04/2024 - 01/2007
28	AntigensIBA 04/2024 - 11/2002
27	Therapeutic UsesIBA 01/2024 - 12/2002
26	Peptides (Polypeptides)IBA 02/2024 - 08/2002
25	EnzymesIBA 04/2024 - 03/2004
25	Peroxidase (Myeloperoxidase)IBA 09/2021 - 11/2005
24	Immunoglobulin G (IgG)IBA 01/2024 - 12/2003
22	Complement System Proteins (Complement)IBA 12/2023 - 01/2005
19	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 11/2013
19	Interleukin-6 (Interleukin 6)IBA 10/2022 - 06/2007
18	Insulin (Novolin)FDA Link 09/2023 - 01/2002
17	CollagenIBA 05/2024 - 03/2005
17	Indicators and Reagents (Reagents)IBA 03/2024 - 01/2014
17	Protons (Proton)IBA 10/2023 - 09/2009
17	RNA (Ribonucleic Acid)IBA 06/2023 - 01/2013
17	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2023 - 02/2006
16	Long Noncoding RNAIBA 05/2024 - 10/2017
16	Hormones (Hormone)IBA 04/2024 - 06/2002
16	Tyrosine Kinase InhibitorsIBA 06/2023 - 07/2012
16	IronIBA 02/2023 - 02/2008
15	C-Reactive ProteinIBA 04/2024 - 04/2006
15	Phosphotransferases (Kinase)IBA 01/2023 - 05/2004
14	LipopolysaccharidesIBA 03/2024 - 08/2015
14	Interleukin-17 (Interleukin 17)IBA 01/2024 - 01/2014
14	CateninsIBA 01/2024 - 09/2011
14	Transcription Factors (Transcription Factor)IBA 09/2023 - 06/2005
13	HMGB1 Protein (HMG1)IBA 02/2024 - 01/2015
13	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 08/2009
13	Triglycerides (Triacylglycerol)IBA 01/2024 - 10/2002
13	AmidesIBA 10/2023 - 02/2013

Therapy/Procedure

203	Therapeutics 05/2024 - 01/2002
52	Drug Therapy (Chemotherapy) 03/2024 - 02/2012
25	Immunotherapy 04/2024 - 05/2003
16	Transplantation 01/2024 - 12/2005
16	Radiotherapy 04/2023 - 01/2014
15	Aftercare (After-Treatment) 01/2023 - 10/2006
13	Cell Transplantation 10/2023 - 01/2016